Effect on the Resistome of Dual vs Monotherapy for the Treatment of Neisseria gonorrhoeae: Results From a Randomized Controlled Trial (ResistAZM Trial)

BACKGROUND: No randomized controlled trial (RCT) has compared the impact on the resistome of ceftriaxone (CRO) plus azithromycin (AZM) vs CRO for the treatment of Neisseria gonorrhoea (NG). METHODS: This was an open-label, single-center, RCT comparing the effect on the resistome of CRO plus AZM vs C...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibaut, Vanbaelen, Eric, Florence, Christophe, Van Dijck, Achilleas, Tsoumanis, Laumen, Jolein Gyonne Elise, Sheeba, Manoharan-Basil Santhini, Saïd, Abdellati, De Block, Tessa, Irith, De Baetselier, Dorien, Van den Bossche, Yven, Van Herrewege, Anke, Rotsaert, Chris, Kenyon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580146/
https://www.ncbi.nlm.nih.gov/pubmed/37854109
http://dx.doi.org/10.1093/ofid/ofad462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580146/
https://www.ncbi.nlm.nih.gov/pubmed/37854109
http://dx.doi.org/10.1093/ofid/ofad462

Ejemplares similares